Self-paying patients can buy the pill for $5 (3.70) a day, or $149 a month, for the starting dose of 1.5mg
Meanwhile, Chinese companies are rapidly advancing through fast following, innovation and licensing, with key developments including Innovents mazdutide, Innogens supaglutide, Hengruis oral candidate HRS-7535, United Laboratories licensing of its first-in-class triple-G (GLP-1, gastric inhibitory polypeptide (GIP) and glucagon) a gonist to Novo Nordisk and Ascletis positive Phase 1 results for its oral + injection candidate, ASC30
Thyroid Nodules and Cancer Screening Patients with pre-existing thyroid nodules should inform their provider before starting semaglutide
This gives patients more control over their health and better manage their diabetes, blood sugar levels, and other bodily functions